Yamin Tan

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Yi Luo, Haowen Xiao, Xiaoyu Lai et al. · Blood · 2014 · 196 citations

Life Sciences, Hematology, Immunology +16

Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia

Yongxian Hu, Zhao Wu, Yi Luo et al. · Clinical Cancer Research · 2016 · 134 citations

Life Sciences, Oncology, Pharmacology +17

Interleukin-6 signaling regulates hematopoietic stem cell emergence

Ruxiu Tie, Honghu Li, Shuyang Cai et al. · Experimental & Molecular Medicine · 2019 · 97 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation

Haowen Xiao, Jimin Shi, Yi Luo et al. · Blood · 2011 · 84 citations

Medicine, Genetics, Hematology +14

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Houli Zhao, Jieping Wei, Guoqing Wei et al. · Journal of Hematology & Oncology · 2020 · 83 citations · Full text

Medicine, Hematology, Oncology +16